Pfizer Leerstoel voor Hypertensie en Cardiovasculair Onderzoek

Faculteit

Geneeskunde

Schenker

Pfizer nv

Datum ondertekening

1 oktober 2004
17 januari 2008 (verlenging)

Duur

3 jaar (01.10.2005-30.09.2007)

Doelstelling

Research in het domein van hypertensie en cardiovasculaire aandoeningen.
Funding will be used in support of the Flemish Study on Environment, Genes and Health Outcomes (Hypertension Unit, Dr. Jan Staessen, Prof. Robert Fagard). This prospective study runs since 1985 and enrolled approximately 3000 participants. Half of the funding will be used to implement phenotyping in this cohort of left-ventricular structure and function, using an innovative approach based on tissue-Doppler-imaging. The other half of the research grant is in support of preclinical and clinical studies of stem cells (Division of Cardiology, Prof. Frans Van de Werf).

Titularis aan de K.U. Leuven

Prof. dr. J. Staessen